Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/109064
Title: How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients.
Author: Brito Zerón, María del Pilar
Gheitasi, Hoda
Retamozo, María Soledad
Bové Boada, Alberto
Londoño, María
Sánchez Tapias, José M. (José María)
Caballero Borrego, Miguel
Kostov, Belchin
Forns, Xavier
Kaveri, Srini V.
Ramos Casals, Manuel
Keywords: Síndrome de Sjögren
Hepatitis
Immunologia
Estudi de casos
Sjogren's syndrome
Hepatitis
Immunology
Case studies
Issue Date: 10-Sep-2015
Publisher: BioMed Central
Abstract: Introduction: We conducted a study to analyze how infection by hepatitis C virus (HCV) may influence the immunological serum pattern of patients with Sjögren syndrome (SS). Methods: Since 1994, we have tested serum HCV-IgG antibodies in 783 patients with SS diagnosed according to the 1993 European classification criteria. The immunological profile at diagnosis was compared according to the presence or absence of HCV. Results: Of the 783 patients with SS, 105 (13.4 %) tested positive for HCV-IgG antibodies (88 females, 17 males,mean age at SS diagnosis: 62.9 years). Multivariate analysis showed that patients with SS-HCV had a higher mean age and a higher frequency of low C3/C4 levels, cryoglobulins, and hematological neoplasia compared with patients without HCV. The frequency of anti-La antibodies compared with anti-Ro antibodies was higher in patients with SS-HCV (17 % vs. 15 %) and lower in patients without HCV infection (30 % vs. 43 %). The frequency of concomitant detection of the three main cryoglobulin-related markers (cryoglobulins, rheumatoid factor activity, and C4 consumption) was threefold higher in patients with SS-HCV compared with patients without HCV. SS-HCV patients with genotype 1b showed the highest frequencies of immunological abnormalities related to cryoglobulins and the lowest frequencies of anti-Ro/La antibodies. Conclusions: We found HCV infection in 13 % of a large series of Spanish patients with SS. The HCV-driven autoimmune response was characterized by a lower frequency of anti-Ro/La antibodies, an abnormal predominance of anti-La among anti-Ro antibodies, and a higher frequency of cryoglobulinemic-related immunological markers in comparison with patients without HCV infection. This immunological pattern may contribute to the poor outcomes found in patients with SS-HCV.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s13075-015-0766-3
It is part of: Arthritis Research & Therapy, 2015, vol. 17, num. 1, p. 250
Related resource: https://doi.org/10.1186/s13075-015-0766-3
URI: http://hdl.handle.net/2445/109064
ISSN: 1478-6362
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
669325.pdf412.63 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons